Advertisement

ZAK Zürich pp 54-61 | Cite as

Medikamentöse Unterstützung der kardialen Wiederbelebung

  • R. Gattiker
Conference paper
Part of the Anaesthesiologie und Intensivmedizin/Anaesthesiology and Intensive Care Medicine book series (A+I, volume 187)

Zusammenfassung

Das Ziel der kardiopulmonalen Reanimation (CPR) ist die möglichst rasche Wiederherstellung der spontanen Herzaktion und einer adäquaten Zirkulation. In der primären Phase werden deshalb Pharmaka gebraucht, die geeignet sind, die mechanischen Maßnahmen der Wiederbelebung zur Oxygenierung des Myokards in sinnvoller Weise zu unterstützen, und solche, die der Bekämpfung von pathologischen Folgezuständen des Kreislaufstillstands und der Wiederbelebungsphase dienen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Anderson RM, Schoch WG, Faxon HH (1950) Cardiac arrest. N Engl J Med 243: 905–909CrossRefGoogle Scholar
  2. 2.
    Babbs CF, Yim GWK, Whistler SJ, Tacker WA, Geddes LA (1979) Elevation of ventricular defibrillation threshold in dogs by antiarrhytmic drugs. Am Heart J 98: 345–350PubMedCrossRefGoogle Scholar
  3. 3.
    Beecher HK, Linton RL (1947) Epinephrin in cardiac resuscitation. JAMA 135: 90Google Scholar
  4. 4.
    Crile G, Dolley DH (1906) An experimental research into the resuscitation of dogs killed by anesthetics and asphycia. J Exp Med 8: 713–715PubMedCrossRefGoogle Scholar
  5. 5.
    Dembo DH (1981) Calcium in advanced life support. Crit Care Med 9: 358–359PubMedCrossRefGoogle Scholar
  6. 6.
    Elam JO (1977) The intrapulmonary route for CPR drugs. In: Safar P (ed) Advances in cardiopulmonary resuscitation. Springer, Berlin Heidelberg New York, pp 132–140CrossRefGoogle Scholar
  7. 7.
    Gattiker R, Schmid E (1978) Haemodynamic effects of dopamine, epinephrine and orciprenaline in patients early after cardiac surgery. Intensive Care Med 4: 55–61PubMedCrossRefGoogle Scholar
  8. 8.
    Gattiker R, Dimai W, Schmid E (1980) Kreislaufuntersuchungen unter Dobutamin und Dopamin nach herzchirurgischen Eingriffen. In: Bleifeld W, Gattiker R, Schaper W, Brade W (Hrsg) Internationales Dobutamin Symposium München 1979. Urban & Schwarzenberg, München Wien Baltimore, S 150–155Google Scholar
  9. 9.
    Goldberg AH (1974) Current concepts: Cardiopulmonary arrest. N Engl J Med 290: 381–385PubMedCrossRefGoogle Scholar
  10. 10.
    Gottlieb R (1896) Über die Wirkung der Nebennierenextrakte auf Herz und Blutdruck. Arch Exp Pathol Pharmacol 38: 99–112CrossRefGoogle Scholar
  11. 11.
    Holmes HR, Babbs CF, Voorhees WD, Tacker WA, de Garavilla B (1980) Influence of adrenergic drugs upon vital organ perfusion during CPR. Crit Care Med 8: 137–140Google Scholar
  12. 12.
    Livesay JJ, Follette DM, Fey KH, Nelson RL, DeLand EC, Barnard RJ,Buckberg GD (1978) Optimizing myocardial supply/demand balance with alpha-adrenergic drugs during cardiopulmonary resuscitation. J Thorac Cardiovasc Surg 76: 244–251PubMedGoogle Scholar
  13. 13.
    Meuret GH, Lenders HG, Schindler HFO, Scholler KL (1983) Orciprenalin (Alupent) in der Reanimation nach Kreislaufstillstand? Anaesthesist 32: 352–358PubMedGoogle Scholar
  14. 14.
    Otto CW, Yakaitis RW, Redding JS, Blitt CD (1981) Comparison of domapine, dobutamine and epinephrine in CPR. Crit Care Med 9: 366PubMedCrossRefGoogle Scholar
  15. 15.
    Pearson JW, Redding JS (1963) The role of epinephrine in cardiac resuscitation. Anesth Anaig 42: 599–606Google Scholar
  16. 16.
    Pearson JW, Redding JS (1965) Influence of peripheral vascular tone on cardiac resuscitation. Anesth Analg 44: 746–752PubMedCrossRefGoogle Scholar
  17. 17.
    Redding JS (1971) Abdominal compression in cardiopulmonary resuscitation. Anesth Analg 50: 668–675PubMedCrossRefGoogle Scholar
  18. 18.
    Redding JS, Pearson JW (1963) Evaluation of drugs for cardiac resuscitation. Anesthesiology 24: 203–207PubMedCrossRefGoogle Scholar
  19. 19.
    Redding JS, Pearson JW (1968) Resuscitation from ventricular fibrillation: Drug therapy. JAMA 203: 255–260PubMedCrossRefGoogle Scholar
  20. 20.
    Redding JS, Asuncion JS, Pearson JW (1967) Effective routes of drug administration during cardiac arrest. Anesth Analg 46: 253–258PubMedCrossRefGoogle Scholar
  21. 21.
    Rothe KF, Diedler J (1982) Comparison of intra- and extracellular buffering of clinically used substances: Tris and bicarbonate. Acta Anaesth Scand 26: 194–195Google Scholar
  22. 22.
    Yakaitis RW, Otto CW, Blitt CD (1979) Relative importance of alpha- and beta-adrenergic receptors during resuscitation. Crit Care Med 7: 293–296PubMedCrossRefGoogle Scholar
  23. 23.
    Zoll PM (1971) Rational use of drugs for cardiac arrest and after cardiac resuscitation. Am J Cardiol 27: 645–649PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • R. Gattiker

There are no affiliations available

Personalised recommendations